Matches in Nanopublications for { ?s ?p "[Impaired fibrinolysis due to increased microvascular expression of the antifibrinolytic PAI-1 in combination with the decreased expression of the profibrinolytic tPA seems to be a final common pathway in renal thrombotic microangiopathy that is also effective in aHUS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP304198.RABYb7vBDVIbmzEQsU6vNZ5R8iNAL0bvX3LX4QoakuOZ8130_assertion description "[Impaired fibrinolysis due to increased microvascular expression of the antifibrinolytic PAI-1 in combination with the decreased expression of the profibrinolytic tPA seems to be a final common pathway in renal thrombotic microangiopathy that is also effective in aHUS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304198.RABYb7vBDVIbmzEQsU6vNZ5R8iNAL0bvX3LX4QoakuOZ8130_provenance.
- NP1012436.RASVvqgRYb-5ReU2PPKfiabYkD1E__31Gl2Fml730DWsQ130_assertion description "[Impaired fibrinolysis due to increased microvascular expression of the antifibrinolytic PAI-1 in combination with the decreased expression of the profibrinolytic tPA seems to be a final common pathway in renal thrombotic microangiopathy that is also effective in aHUS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1012436.RASVvqgRYb-5ReU2PPKfiabYkD1E__31Gl2Fml730DWsQ130_provenance.
- NP1059239.RAQJzpsIVtrPSH8TXCWfGy37GlZERcp40OqcHGab2A1X8130_assertion description "[Impaired fibrinolysis due to increased microvascular expression of the antifibrinolytic PAI-1 in combination with the decreased expression of the profibrinolytic tPA seems to be a final common pathway in renal thrombotic microangiopathy that is also effective in aHUS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1059239.RAQJzpsIVtrPSH8TXCWfGy37GlZERcp40OqcHGab2A1X8130_provenance.
- assertion description "[Impaired fibrinolysis due to increased microvascular expression of the antifibrinolytic PAI-1 in combination with the decreased expression of the profibrinolytic tPA seems to be a final common pathway in renal thrombotic microangiopathy that is also effective in aHUS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Impaired fibrinolysis due to increased microvascular expression of the antifibrinolytic PAI-1 in combination with the decreased expression of the profibrinolytic tPA seems to be a final common pathway in renal thrombotic microangiopathy that is also effective in aHUS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP607766.RAnaW-AkmW3dAPpRGnlVElprvaW9B5N_nU-ke-ygk8b6c130_assertion description "[Impaired fibrinolysis due to increased microvascular expression of the antifibrinolytic PAI-1 in combination with the decreased expression of the profibrinolytic tPA seems to be a final common pathway in renal thrombotic microangiopathy that is also effective in aHUS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607766.RAnaW-AkmW3dAPpRGnlVElprvaW9B5N_nU-ke-ygk8b6c130_provenance.
- NP1059238.RAJEQrzMcVwd5V02O8rDYeJGGH-MQLy8nvAIfhztsWpg8130_assertion description "[Impaired fibrinolysis due to increased microvascular expression of the antifibrinolytic PAI-1 in combination with the decreased expression of the profibrinolytic tPA seems to be a final common pathway in renal thrombotic microangiopathy that is also effective in aHUS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1059238.RAJEQrzMcVwd5V02O8rDYeJGGH-MQLy8nvAIfhztsWpg8130_provenance.